Biothera Research Papers & Presentations
Research demonstrating the safety and efficacy of Biothera compounds is the source of numerous peer-reviewed articles and presentations to scientific forums.
February 2012 A poster presentation at the Keystone Symposia, Innate Immunity: Sensing the Microbes and Damage Signals. Keystone, Colorado
June 2011 Blood 2011 117:6825-6836; doi:10.1182/blood-2011-02-339812
June 2011 Imprime PGG Plus Cetuximab Therapy for Advanced KRAS Mutant Colorectal Cancer A poster presentation at the European Society for Medical Oncology 13th World Congress on Gastrointestinal Cancer. Barcelona, Spain
April 2011 Activation of the innate immune receptor Dectin-1 upon formation of a ‘phagocytic synapse’ Nature 472, 471–475 (28 April 2011) doi:10.1038/nature10071
February 2010 A poster presentation at the Molecular Medicine Tri-Conference San Francisco
October 2009 Antitumor Activity of Soluble Beta-1,3/1,6 Glucans: Structure Matters Frontiers in Basic Immunology 2009, Bethesda, MD. Sponsored by the National Cancer Institute.
August 2008 Analysis of Side Chain Lengths of Branched β-1,3-Glucans by Alkaline Degradation.
March 2008 Mobilization of Hematopoietic Progenitor Cells by Yeast-derived ß-Glucan Requires Activation of Matrix Metalloproteinase-9. Stem Cells published online Mar 13, 2008; DOI: 10.1634/stemcells.2007-0712.
March 2008 A poster presentation at Keystone Symposia's conference on Innate Immunity: Signaling Mechanisms.
February 2008 Yeast-Derived β-Glucan Augments the Therapeutic Efficacy Mediated by Anti-Vascular Endothelial Growth Factor Monoclonal Antibody in Human Carcinoma Xenograft Models. Cancer Research. 2007 67: 7421-7430.
December 2006 β-Glucan is a Fungal Determinant for Adhesion-Dependent Human Neutrophil Functions. Journal of Immunology. Dec 2006; 177: 8667 - 8675.
August 2006
April 2006
June 2005
September 2004
March 2004
December 2003
March 2003
|
 |
|
|
|
|
|
|
|
|
|
